Intermittent Claudication: Clinical Trials

306 trials for Intermittent Claudication, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

180 completed, 56 unknown, 28 recruiting, 19 terminated. 145 Not applicable, 34 Phase 2, 28 Phase 4, 25 Phase 3, 24 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable145Completed 85, Unknown 25, Recruiting 19, Terminated 5, Not yet recruiting 4, Withdrawn 4, Active not recruiting 2, Enrolling by invitation 1
Phase 234Completed 20, Unknown 8, Not yet recruiting 2, Recruiting 2, Terminated 1, Withdrawn 1
Phase 428Completed 16, Unknown 5, Terminated 4, Withdrawn 2, Recruiting 1
Phase 325Completed 14, Terminated 4, Unknown 4, Recruiting 2, Not yet recruiting 1
Phase 124Completed 17, Terminated 2, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1

Follow Intermittent Claudication: new trials by email Literature Review of Intermittent Claudication trials Research Report on Intermittent Claudication

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
FGF-1, Placebo - Peripheral Arterial Disease, Stenosis
Phase 1 / Phase 2Not yet recruitingVenturis Therapeutics, Inc.242028-10-152026-08-19
The NICE-PAD II Trial
Nicotinamide Riboside (NR), Placebo - Peripheral Artery Disease (PAD)
Phase 3Not yet recruitingNorthwestern University2502026-12-012026-08-24
Evaluation of the Effectiveness of Hybrid Cardiac Rehabilitation in Peripheral Artery Disease
Hybrid Cardiac Rehabilitation, Supervised Exercise Therapy - Peripheral Arterial Disease
Not applicableNot yet recruitingBiruni University402026-09-162026-04-24
Predictors of Major Adverse Limb Events After Endovascular Iliac Stenting: a Real-world Cohort Study
Iliac stenting - Peripheral Arterial Disease, Aortoiliac Occlusive Disease
RecruitingI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio982026-06-162026-06-30
Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia
Analysis of GLP-1 receptor expression - Peripheral Arterial Disease (PAD), Claudication, Intermittent
Not yet recruitingUniversity Hospital, Strasbourg, France502026-06-012026-01-14
CT Body Composition as Predictor of Exercise Therapy Outcome in Peripheral Arterial Disease
SET physiotherapy, CT scan - Sarcopenia, Body Composition
Not yet recruitingNemocnice AGEL Trinec-Podlesi a.s.1282026-06-012026-02-25
Recreational Team Handball Programme for Patients With Peripheral Arterial Disease
Recreational team handball programme - Peripheral Arterial Disease (PAD)
Not applicableNot yet recruitingUniversity Institute of Maia602026-05-142026-05-13
EVERO Drug-coated Balloon (DCB) Randomized Trial
Evero DCB, Paclitaxel DCB - Peripheral Vascular Disease, Peripheral Arterial Disease
Not applicableRecruitingCook Research Incorporated4102026-04-172026-10-13
Evaluation of Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients With Peripheral Arterial Disease
Etribnabdione 25 mg BID, Etribnabdione 50 mg BID - Peripheral Arterial Disease
Phase 2Not yet recruitingVivaCell Biotechnology España302026-01-012025-09-17
Presence of Dural Pulsation in Patients Diagnosed With Lumbar Spinal Stenosis
Lumbar Spinal Stenosis, Numerical Rating Scale
RecruitingMarmara University1002025-12-072026-03-11
Acute Effects of Exercise in Peripheral Arterial Disease Patients
Aerobic exercise, Traditional strength exercise, Circuit strength exercise - Aerobic Physical Exercise, Traditional Strength Exercise
Not applicableNot yet recruitingEuropean University Miguel de Cervantes162025-12-012025-12-01
Observing the Role of Inflammation in Peripheral Artery Disease and Its Impact on Heart and Mobility Health: PANACEA-O.
Peripheral Vascular Disease
RecruitingCardiology Research UBC502025-09-252026-03-30
Improving Mobility After Revascularization in Peripheral Artery Disease
Home Based Exercise, Nitrate Rich Beetroot Juice, Attention Control - Peripheral Artery Disease, Intermittent Claudication
Phase 3RecruitingNorthwestern University3862025-08-042026-10-05
Personalised Multicomponent Exercise Programme in Peripheral Arterial Disease
Exercise, Usual care - Peripheral Arterial Disease, Intermittent Claudication
Not applicableRecruitingUniversity of Trás-os-Montes and Alto Douro402025-06-202025-06-27
Heat Therapy and Peripheral Artery Disease
Heat Therapy Intervention - Peripheral Arterial Disease, Cardiovascular Health
Not applicableNot yet recruitingManchester Metropolitan University702025-05-012025-02-14
Local or Systemic Effects: Mechanisms Related to Arm Crank Exercise - Comparison Between Individuals With and Without PAD
Exercise - Peripheral Arterial Disease
Not applicableEnrolling by invitationUniversity of Nove de Julho242025-03-242026-04-13
Response to Exercise and Nitric Oxide in PAD
Supervised Treadmill Exercise, Attention Control, Nitrate-Rich Beetroot Juice + supervised exercise therapy - Peripheral Artery Disease, Exercise
Phase 2RecruitingNorthwestern University2002025-01-232026-07-27
Heat Therapy for Peripheral Arterial Disease (HEATPAD)
AirGlove - Peripheral Arterial Disease, Intermittent Claudication
Not applicableWithdrawnNorfolk and Norwich University Hospitals NHS Foundation Trust2025-01-012026-06-09
Fisetin to Reduce Senescence and Mobility Impairment in PAD
Fisetin, Placebo - Peripheral Arterial Disease, Aging
Phase 2RecruitingNorthwestern University342024-09-302026-04-15
The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
DASH Diet plus Home-Based Exercise, Home-Based Exercise - Claudication, Peripheral Artery Disease
Not applicableRecruitingUniversity of Oklahoma1502024-09-162026-04-17

Showing 20 of 306. Sign in to see all of them.

Narrower conditions

Peripheral Arterial Disease (200)  ·  Peripheral Vascular Diseases (67)  ·  Atherosclerosis (34)  ·  Chronic Limb-Threatening Ischemia (34)  ·  Motor Activity (18)  ·  Arterial Occlusive Diseases (17)  ·  Vascular Diseases (15)  ·  Cardiovascular Diseases (14)  ·  Peripheral Arterial Occlusive Disease 1 (9)  ·  Inflammation (6)  ·  Spinal Stenosis (5)  ·  Arteriosclerosis (4)  ·  Mobility Limitation (4)  ·  Thrombosis (4)

Broader conditions

Pathological Conditions, Signs and Symptoms (306)  ·  Signs and Symptoms (304)  ·  Cardiovascular Diseases (292)  ·  Vascular Diseases (291)  ·  Peripheral Vascular Diseases (239)  ·  Arteriosclerosis (218)  ·  Arterial Occlusive Diseases (212)  ·  Atherosclerosis (187)  ·  Peripheral Arterial Disease (106)  ·  Pathologic Processes (48)  ·  Chronic Disease (35)  ·  Disease Attributes (35)  ·  Ischemia (34)  ·  Behavior (22)  ·  Nervous System Diseases (13)

Interventions

Exercise (15)  ·  Cilostazol (13)  ·  Angioplasty (12)  ·  Aspirin (7)  ·  Clopidogrel (4)  ·  Exercise Therapy (4)  ·  Atherectomy (3)  ·  BID protein, human (3)  ·  Control Groups (3)  ·  Exercise Test (3)  ·  Stents (3)  ·  Acupuncture Therapy (2)  ·  Arginine (2)  ·  Intermittent Pneumatic Compression Devices (2)  ·  Lovastatin (2)

Sponsors

University Hospital, Angers (11)  ·  Abbott Medical Devices (6)  ·  Genovate Biotechnology Co., Ltd., (6)  ·  Medtronic Endovascular (6)  ·  Northwestern University (6)  ·  Copenhagen University Hospital at Herlev (5)  ·  Hull University Teaching Hospitals NHS Trust (5)  ·  National Heart, Lung, and Blood Institute (NHLBI) (5)  ·  Sahlgrenska University Hospital (5)  ·  Flanders Medical Research Program (4)  ·  Imperial College London (4)  ·  Norwegian University of Science and Technology (4)  ·  University of California, San Francisco (4)  ·  University of Minnesota (4)  ·  University of Oklahoma (4)

Countries

United States (118)  ·  Germany (30)  ·  United Kingdom (26)  ·  France (20)  ·  Austria (15)  ·  Belgium (13)  ·  Sweden (12)  ·  Brazil (10)  ·  Denmark (10)  ·  Netherlands (9)  ·  New Zealand (9)  ·  Canada (8)  ·  Norway (7)  ·  South Korea (7)  ·  Italy (6)

Top investigators

Marc Bosiers, MD (4)  ·  Henrik S Thomsen, Prof. MD. (3)  ·  Pierre Abraham, MD, PhD (3)  ·  Raphael Ritti-Dias, PhD (3)  ·  Thomas Zeller, MD (3)  ·  Andrew W Gardner, PhD (2)  ·  Andrew W. Gardner, PhD (2)  ·  Daniel V Freeland, DO (2)  ·  Gabriel Cucato, PhD (2)  ·  Garry A Tew, PhD (2)  ·  John H. Rundback, M.D. (2)  ·  Jonny Hisdal, PhD (2)  ·  Manish Mehta, MD, MPH (2)  ·  Oliver O Aalami, MD (2)

Results publications

PMID 21262997, PMID 25237048, PMID 42573020, PMID 16242558, PMID 31912491, PMID 42035974, PMID 10650308, PMID 10666287, PMID 10777236, PMID 10805617, PMID 1100130, PMID 11034229, PMID 11300450, PMID 11368702, PMID 11454114, PMID 11581152, PMID 11789964, PMID 11790215, PMID 12042688, PMID 12485966, PMID 12495171, PMID 12610004, PMID 12668524, PMID 12850465, PMID 14981444, PMID 15389223, PMID 15451914, PMID 15678616, PMID 16449620, PMID 16520719, PMID 16678694, PMID 17026909, PMID 17110509, PMID 17126520, PMID 17223489, PMID 17264010, PMID 17299195, PMID 17353883, PMID 17374814, PMID 17543683, PMID 17617342, PMID 18270378, PMID 18362433, PMID 18388038, PMID 18612130, PMID 18628657, PMID 18675557, PMID 18774340, PMID 18783958, PMID 19028055

NIH funding

1RC2HL101515-01 (1), 2004 (1), 2005 (1), 2009 (1), 2017 (1), I01CX002150 (1), I21RX001927 (1), K01AG000657 (1), K01HL115534 (1), R01AG016685 (1), R01AG024296 (1), R01AG034995 (1), R01AG057693 (1), R01AG070086 (1), R01AG071778 (1)